This inventor holds 1 USPTO granted patent and 9 published patent applications and 2 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Halozyme, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,736 
1 out of 85 
Years Active: 2026
Title: Akintunde Bello: Innovator in Tumor Treatment
Introduction
Akintunde Bello is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medical technology, particularly in the treatment of tumors. His innovative approach has led to the development of a patent that addresses critical challenges in oncology.
Latest Patents
Akintunde Bello holds a patent titled "Methods of Treating Tumors." This patent represents his commitment to advancing medical treatments and improving patient outcomes. He has successfully secured 1 patent that showcases his expertise and dedication to innovation in the medical field.
Career Highlights
Throughout his career, Akintunde Bello has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Halozyme, Inc. and Bristol-Myers Squibb Company, where he contributed to various projects aimed at enhancing therapeutic solutions. His experience in these organizations has enriched his knowledge and skills in the industry.
Collaborations
One of his notable collaborators is Masano Huang. Their partnership has likely fostered innovative ideas and solutions in their respective fields.
Conclusion
Akintunde Bello's work in tumor treatment exemplifies the impact of innovation in healthcare. His patent and collaborations reflect his dedication to improving medical therapies and patient care.